Jarrod Mullen is set to face the Newcastle Local Court on June 20 after he was charged due to his alleged involvement in a cocaine ring, according to the Sydney Morning Herald.

The 32-year-old has been charged with supplying the prohibited substance in the Newcastle and Lake Macquarie areas between September and December of last year.

Mullen was arrested and taken into Wollongong Police Station Wednesday morning, where he was later arrested for three counts of supplying cocaine and one count of supplying a trafficable amount of an illegal drug.

Mullen becomes the eighth person to be charged in relation to this alleged drug syndicate by the Detectives attached to Strike Force Castlestead.

"Strike Force Castlestead was formed in September 2018 to investigate and dismantle an alleged drug supply syndicate operating across the Newcastle City and Lake Macquarie Police Districts," NSW Police said in a statement.

In 2017, Mullen failed a drug test which saw him test positive to anabolic steroid, Drostanolone, in an attempt to assist him with his recovery from a hamstring injury.

This resulted in the League serving a four-year ban, which may have ultimately ended his career.

The following year, Mullen was placed in intensive care for two days after a drug overdose, according to sportingnews.com.au, where he almost lost his life.

After he was cleared and discharged from hospital, Mullen was sent to rehab for six weeks.

The Knight has struggled to adapt to life since the suspension, which has seen a downward spiral from an illustrious career to one hindered by off-field antics.

Both the club (Newcastle) and ASADA have offered their services to try and help the troubled Mullen.

He made his debut in 2005 as an 18-year-old against West Tigers. Since then, Mullen has played in 211 games over 12 seasons for the Knights.

He played just one game in State of Origin as a 20-year-old for New South Wales.

1 COMMENT

  1. Played his career on drugs why would he have stopped being involved with them when he has been sacked

Comments are closed.